Home › Funds › Patient Capital Management, LLC › NCLH

Patient Capital Management, LLC position in NCLH

NORWEGIAN CRUISE LINE HLDGS · Consumer Discretionary

Patient Capital Management, LLC reported holding 5,972,382 shares of NCLH (NORWEGIAN CRUISE LINE HLDGS) in its Q3 2026 13F filing — a position valued at US$87.6M, representing 2.96% of its reported portfolio and ranking #14 among its reported holdings. Patient Capital Management, LLC has disclosed NCLH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.97M sh
Reported value held$87.56M
Portfolio Weight2.96%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Capital Management, LLC's NCLH position evolved

Patient Capital Management, LLC first disclosed a stake in NCLH in Q3 2023 at 2,534,597 shares (US$41.8M). The position peaked in Q2 2026 at 6,029,642 shares, worth US$127.3M. Across 13 filings, Patient Capital Management, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,972,382 shares valued at US$87.6M — a reduction of -57,260 shares quarter over quarter.. Notable position changes include a 45% increase in Q1 2025 (shares rose 7% over the following quarter), a 31% increase in Q2 2025 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.53M $41.77M New
Q4 2023 2.53M $50.77M Hold
Q1 2024 2.41M $50.51M Reduce
Q2 2024 2.84M $53.31M Add
Q3 2024 2.80M $57.47M Reduce
Q4 2024 2.48M $63.91M Reduce
Q1 2025 3.59M $68.07M Add
Q2 2025 4.71M $95.49M Add
Q3 2025 4.56M $112.43M Reduce
Q4 2025 5.31M $118.48M Add
Q1 2026 5.75M $107.52M Add
Q2 2026 6.03M $127.29M Add
Q3 2026 5.97M $87.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NCLH and 13F data

NCLH (NORWEGIAN CRUISE LINE HLDGS) is a Consumer Discretionary company. 30 other funds we track also report a position in NCLH — the largest reported positions include Elliott Investment Management (US$310.0M), ARIEL INVESTMENTS, LLC (US$216.0M), Nearwater Capital Markets, Ltd (US$199.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NCLH

All NCLH fund holders →

FAQ

How long has Patient Capital Management, LLC held NCLH?

Patient Capital Management, LLC has disclosed NCLH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Patient Capital Management, LLC's current position in NCLH?

As of Q3 2026, Patient Capital Management, LLC holds 5.97M shares of NCLH (NORWEGIAN CRUISE LINE HLDGS), valued at $87.56M, representing 2.96% of its reported portfolio and ranking #14.

Has Patient Capital Management, LLC been buying or selling NCLH?

In the latest 13F filing (Q3 2026), Patient Capital Management, LLC reduced its position in NCLH. The position peaked in Q2 2026 at 6.03M shares.

Which other funds hold NCLH?

Other major institutional holders of NCLH include Elliott Investment Management, ARIEL INVESTMENTS, LLC, Nearwater Capital Markets, Ltd, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.